Add time:07/23/2019         Source:sciencedirect.com

The aim of this study was to identify a candidate drug for the development of anti-tuberculosis therapy from previously synthesized compounds based on the thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide/hydrazones compounds. The minimal inhibitory concentration (MIC) of these compounds against Mycobacterium tuberculosis was determined. Their in vitro cytotoxicity to J774 cells (IC50) was determined to establish a selectivity index (SI) (SI = IC50/MIC). The best compounds were the thiosemicarbazones (2, 3 and 4) and the hydrazide/hydrazones (14, 15, 16 and 18). The results are comparable to or better than those of “first line” or “second line” drugs commonly used to treat TB, suggesting these compounds as anti-TB drug candidates.

We also recommend Trading Suppliers and Manufacturers of 1-(4-Methyl-2-pyridyl)-1-pentanone semicarbazone (cas 100317-81-5). Pls Click Website Link as below: cas 100317-81-5 suppliers